“The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam”, Clinics, vol. 68, no. 4, pp. 569–573, Apr. 2013, doi: 10.1590/clin.v68i4.76804.